1 Study Coverage
    1.1 Allergy Immunotherapy Product Introduction
    1.2 Market by Type
        1.2.1 Global Allergy Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Subcutaneous Immunotherapy
        1.2.3 Sublingual Immunotherapy
    1.3 Market by Application
        1.3.1 Global Allergy Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Allergic Rhinitis
        1.3.3 Allergic Asthma
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Allergy Immunotherapy Sales Estimates and Forecasts 2017-2028
    2.2 Global Allergy Immunotherapy Revenue Estimates and Forecasts 2017-2028
    2.3 Global Allergy Immunotherapy Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Allergy Immunotherapy Sales by Region
        2.4.1 Global Allergy Immunotherapy Sales by Region (2017-2022)
        2.4.2 Global Sales Allergy Immunotherapy by Region (2023-2028)
    2.5 Global Allergy Immunotherapy Revenue by Region
        2.5.1 Global Allergy Immunotherapy Revenue by Region (2017-2022)
        2.5.2 Global Allergy Immunotherapy Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Allergy Immunotherapy Sales by Manufacturers
        3.1.1 Global Top Allergy Immunotherapy Manufacturers by Sales (2017-2022)
        3.1.2 Global Allergy Immunotherapy Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Allergy Immunotherapy in 2021
    3.2 Global Allergy Immunotherapy Revenue by Manufacturers
        3.2.1 Global Allergy Immunotherapy Revenue by Manufacturers (2017-2022)
        3.2.2 Global Allergy Immunotherapy Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Allergy Immunotherapy Revenue in 2021
    3.3 Global Allergy Immunotherapy Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Allergy Immunotherapy Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Allergy Immunotherapy Sales by Type
        4.1.1 Global Allergy Immunotherapy Historical Sales by Type (2017-2022)
        4.1.2 Global Allergy Immunotherapy Forecasted Sales by Type (2023-2028)
        4.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    4.2 Global Allergy Immunotherapy Revenue by Type
        4.2.1 Global Allergy Immunotherapy Historical Revenue by Type (2017-2022)
        4.2.2 Global Allergy Immunotherapy Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    4.3 Global Allergy Immunotherapy Price by Type
        4.3.1 Global Allergy Immunotherapy Price by Type (2017-2022)
        4.3.2 Global Allergy Immunotherapy Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Allergy Immunotherapy Sales by Application
        5.1.1 Global Allergy Immunotherapy Historical Sales by Application (2017-2022)
        5.1.2 Global Allergy Immunotherapy Forecasted Sales by Application (2023-2028)
        5.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    5.2 Global Allergy Immunotherapy Revenue by Application
        5.2.1 Global Allergy Immunotherapy Historical Revenue by Application (2017-2022)
        5.2.2 Global Allergy Immunotherapy Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    5.3 Global Allergy Immunotherapy Price by Application
        5.3.1 Global Allergy Immunotherapy Price by Application (2017-2022)
        5.3.2 Global Allergy Immunotherapy Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Allergy Immunotherapy Market Size by Type
        6.1.1 North America Allergy Immunotherapy Sales by Type (2017-2028)
        6.1.2 North America Allergy Immunotherapy Revenue by Type (2017-2028)
    6.2 North America Allergy Immunotherapy Market Size by Application
        6.2.1 North America Allergy Immunotherapy Sales by Application (2017-2028)
        6.2.2 North America Allergy Immunotherapy Revenue by Application (2017-2028)
    6.3 North America Allergy Immunotherapy Market Size by Country
        6.3.1 North America Allergy Immunotherapy Sales by Country (2017-2028)
        6.3.2 North America Allergy Immunotherapy Revenue by Country (2017-2028)
7 Europe
    7.1 Europe Allergy Immunotherapy Market Size by Type
        7.1.1 Europe Allergy Immunotherapy Sales by Type (2017-2028)
        7.1.2 Europe Allergy Immunotherapy Revenue by Type (2017-2028)
    7.2 Europe Allergy Immunotherapy Market Size by Application
        7.2.1 Europe Allergy Immunotherapy Sales by Application (2017-2028)
        7.2.2 Europe Allergy Immunotherapy Revenue by Application (2017-2028)
    7.3 Europe Allergy Immunotherapy Market Size by Country
        7.3.1 Europe Allergy Immunotherapy Sales by Country (2017-2028)
        7.3.2 Europe Allergy Immunotherapy Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Allergy Immunotherapy Market Size by Type
        8.1.1 Asia Pacific Allergy Immunotherapy Sales by Type (2017-2028)
        8.1.2 Asia Pacific Allergy Immunotherapy Revenue by Type (2017-2028)
    8.2 Asia Pacific Allergy Immunotherapy Market Size by Application
        8.2.1 Asia Pacific Allergy Immunotherapy Sales by Application (2017-2028)
        8.2.2 Asia Pacific Allergy Immunotherapy Revenue by Application (2017-2028)
    8.3 Asia Pacific Allergy Immunotherapy Market Size by Region
        8.3.1 Asia Pacific Allergy Immunotherapy Sales by Region (2017-2028)
        8.3.2 Asia Pacific Allergy Immunotherapy Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Allergy Immunotherapy Market Size by Type
        9.1.1 Latin America Allergy Immunotherapy Sales by Type (2017-2028)
        9.1.2 Latin America Allergy Immunotherapy Revenue by Type (2017-2028)
    9.2 Latin America Allergy Immunotherapy Market Size by Application
        9.2.1 Latin America Allergy Immunotherapy Sales by Application (2017-2028)
        9.2.2 Latin America Allergy Immunotherapy Revenue by Application (2017-2028)
    9.3 Latin America Allergy Immunotherapy Market Size by Country
        9.3.1 Latin America Allergy Immunotherapy Sales by Country (2017-2028)
        9.3.2 Latin America Allergy Immunotherapy Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Allergy Immunotherapy Market Size by Type
        10.1.1 Middle East and Africa Allergy Immunotherapy Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Allergy Immunotherapy Revenue by Type (2017-2028)
    10.2 Middle East and Africa Allergy Immunotherapy Market Size by Application
        10.2.1 Middle East and Africa Allergy Immunotherapy Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Allergy Immunotherapy Revenue by Application (2017-2028)
    10.3 Middle East and Africa Allergy Immunotherapy Market Size by Country
        10.3.1 Middle East and Africa Allergy Immunotherapy Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Allergy Immunotherapy Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 ALK-Abello
        11.1.1 ALK-Abello Corporation Information
        11.1.2 ALK-Abello Overview
        11.1.3 ALK-Abello Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 ALK-Abello Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 ALK-Abello Recent Developments
    11.2 Stallergenes Greer
        11.2.1 Stallergenes Greer Corporation Information
        11.2.2 Stallergenes Greer Overview
        11.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Stallergenes Greer Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Stallergenes Greer Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Allergy Therapeutics
        11.4.1 Allergy Therapeutics Corporation Information
        11.4.2 Allergy Therapeutics Overview
        11.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Allergy Therapeutics Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Allergy Therapeutics Recent Developments
    11.5 HAL
        11.5.1 HAL Corporation Information
        11.5.2 HAL Overview
        11.5.3 HAL Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 HAL Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 HAL Recent Developments
    11.6 Holister Stier
        11.6.1 Holister Stier Corporation Information
        11.6.2 Holister Stier Overview
        11.6.3 Holister Stier Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Holister Stier Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Holister Stier Recent Developments
    11.7 Leti
        11.7.1 Leti Corporation Information
        11.7.2 Leti Overview
        11.7.3 Leti Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Leti Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Leti Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Allergy Immunotherapy Industry Chain Analysis
    12.2 Allergy Immunotherapy Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Allergy Immunotherapy Production Mode & Process
    12.4 Allergy Immunotherapy Sales and Marketing
        12.4.1 Allergy Immunotherapy Sales Channels
        12.4.2 Allergy Immunotherapy Distributors
    12.5 Allergy Immunotherapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Allergy Immunotherapy Industry Trends
    13.2 Allergy Immunotherapy Market Drivers
    13.3 Allergy Immunotherapy Market Challenges
    13.4 Allergy Immunotherapy Market Restraints
14 Key Findings in The Global Allergy Immunotherapy Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Allergy Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Subcutaneous Immunotherapy
    Table 3. Major Manufacturers of Sublingual Immunotherapy
    Table 4. Global Allergy Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Allergy Immunotherapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)
    Table 7. Global Allergy Immunotherapy Sales Market Share by Region (2017-2022)
    Table 8. Global Allergy Immunotherapy Sales by Region (2023-2028) & (K Units)
    Table 9. Global Allergy Immunotherapy Sales Market Share by Region (2023-2028)
    Table 10. Global Allergy Immunotherapy Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Allergy Immunotherapy Revenue Market Share by Region (2017-2022)
    Table 12. Global Allergy Immunotherapy Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Allergy Immunotherapy Revenue Market Share by Region (2023-2028)
    Table 14. Global Allergy Immunotherapy Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Allergy Immunotherapy Sales Share by Manufacturers (2017-2022)
    Table 16. Global Allergy Immunotherapy Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Allergy Immunotherapy Revenue Share by Manufacturers (2017-2022)
    Table 18. Allergy Immunotherapy Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Allergy Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2021)
    Table 21. Allergy Immunotherapy Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Allergy Immunotherapy Product Offered
    Table 23. Date of Manufacturers Enter into Allergy Immunotherapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 26. Global Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 27. Global Allergy Immunotherapy Sales Share by Type (2017-2022)
    Table 28. Global Allergy Immunotherapy Sales Share by Type (2023-2028)
    Table 29. Global Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Allergy Immunotherapy Revenue Share by Type (2017-2022)
    Table 32. Global Allergy Immunotherapy Revenue Share by Type (2023-2028)
    Table 33. Allergy Immunotherapy Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Allergy Immunotherapy Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 36. Global Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 37. Global Allergy Immunotherapy Sales Share by Application (2017-2022)
    Table 38. Global Allergy Immunotherapy Sales Share by Application (2023-2028)
    Table 39. Global Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Allergy Immunotherapy Revenue Share by Application (2017-2022)
    Table 42. Global Allergy Immunotherapy Revenue Share by Application (2023-2028)
    Table 43. Allergy Immunotherapy Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Allergy Immunotherapy Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 46. North America Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 47. North America Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 50. North America Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 51. North America Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
    Table 54. North America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
    Table 55. North America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Allergy Immunotherapy Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Allergy Immunotherapy Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Allergy Immunotherapy Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Allergy Immunotherapy Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Allergy Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Allergy Immunotherapy Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Allergy Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 105. ALK-Abello Corporation Information
    Table 106. ALK-Abello Description and Major Businesses
    Table 107. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. ALK-Abello Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. ALK-Abello Recent Developments
    Table 110. Stallergenes Greer Corporation Information
    Table 111. Stallergenes Greer Description and Major Businesses
    Table 112. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Stallergenes Greer Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Stallergenes Greer Recent Developments
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Major Businesses
    Table 117. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Merck Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Merck Recent Developments
    Table 120. Allergy Therapeutics Corporation Information
    Table 121. Allergy Therapeutics Description and Major Businesses
    Table 122. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Allergy Therapeutics Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Allergy Therapeutics Recent Developments
    Table 125. HAL Corporation Information
    Table 126. HAL Description and Major Businesses
    Table 127. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. HAL Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. HAL Recent Developments
    Table 130. Holister Stier Corporation Information
    Table 131. Holister Stier Description and Major Businesses
    Table 132. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Holister Stier Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Holister Stier Recent Developments
    Table 135. Leti Corporation Information
    Table 136. Leti Description and Major Businesses
    Table 137. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Leti Allergy Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Leti Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Allergy Immunotherapy Distributors List
    Table 143. Allergy Immunotherapy Customers List
    Table 144. Allergy Immunotherapy Market Trends
    Table 145. Allergy Immunotherapy Market Drivers
    Table 146. Allergy Immunotherapy Market Challenges
    Table 147. Allergy Immunotherapy Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Allergy Immunotherapy Product Picture
    Figure 3. Global Allergy Immunotherapy Market Share by Type in 2021 & 2028
    Figure 3. Subcutaneous Immunotherapy Product Picture
    Figure 4. Sublingual Immunotherapy Product Picture
    Figure 5. Global Allergy Immunotherapy Market Share by Application in 2021 & 2028
    Figure 6. Allergic Rhinitis
    Figure 7. Allergic Asthma
    Figure 8. Others
    Figure 9. Allergy Immunotherapy Report Years Considered
    Figure 10. Global Allergy Immunotherapy Sales 2017-2028 (K Units)
    Figure 11. Global Allergy Immunotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Allergy Immunotherapy Revenue 2017-2028 (US$ Million)
    Figure 13. Global Allergy Immunotherapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Allergy Immunotherapy Sales Market Share by Region (2017-2022)
    Figure 15. Global Allergy Immunotherapy Sales Market Share by Region (2023-2028)
    Figure 16. North America Allergy Immunotherapy Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Allergy Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Allergy Immunotherapy Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Allergy Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Allergy Immunotherapy Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Allergy Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Allergy Immunotherapy Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Allergy Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Allergy Immunotherapy Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Allergy Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Allergy Immunotherapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Allergy Immunotherapy in the World: Market Share by Allergy Immunotherapy Revenue in 2021
    Figure 28. Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 30. Global Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 31. Global Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 32. Global Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 33. North America Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 34. North America Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 35. North America Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 36. North America Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 37. North America Allergy Immunotherapy Sales Share by Country (2017-2028)
    Figure 38. North America Allergy Immunotherapy Revenue Share by Country (2017-2028)
    Figure 39. Europe Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 40. Europe Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 41. Europe Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 42. Europe Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 43. Europe Allergy Immunotherapy Sales Share by Country (2017-2028)
    Figure 44. Europe Allergy Immunotherapy Revenue Share by Country (2017-2028)
    Figure 45. Germany Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 46. France Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 47. U.K. Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 48. Italy Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 49. Russia Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 50. Asia Pacific Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 51. Asia Pacific Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 53. Asia Pacific Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Allergy Immunotherapy Sales Share by Region (2017-2028)
    Figure 55. Asia Pacific Allergy Immunotherapy Revenue Share by Region (2017-2028)
    Figure 56. China Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 57. Japan Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 58. South Korea Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 59. India Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 60. Australia Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 61. China Taiwan Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 62. Indonesia Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 63. Thailand Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 64. Malaysia Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 65. Latin America Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 66. Latin America Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 67. Latin America Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 68. Latin America Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 69. Latin America Allergy Immunotherapy Sales Share by Country (2017-2028)
    Figure 70. Latin America Allergy Immunotherapy Revenue Share by Country (2017-2028)
    Figure 71. Mexico Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 72. Brazil Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 73. Argentina Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 74. Middle East and Africa Allergy Immunotherapy Sales Market Share by Type (2017-2028)
    Figure 75. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Allergy Immunotherapy Sales Market Share by Application (2017-2028)
    Figure 77. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Allergy Immunotherapy Sales Share by Country (2017-2028)
    Figure 79. Middle East and Africa Allergy Immunotherapy Revenue Share by Country (2017-2028)
    Figure 80. Turkey Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 81. Saudi Arabia Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 82. UAE Allergy Immunotherapy Revenue (2017-2028) & (US$ Million)
    Figure 83. Allergy Immunotherapy Value Chain
    Figure 84. Allergy Immunotherapy Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed